Wesley Buijsman

Wesley Buijsman

Auto-generated profile, based on publicly available information

Wesley Buijsman

Applied Stem Cell Technologies

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2020 in Lab on a Chip
Verified
Journal Article
Open access
PDF file
YAYusuf Bilgehan Arık
Yusuf Bilgehan Arık
WBWesley Buijsman
Wesley Buijsman
JLJoshua Loessberg-Zahl
Joshua Loessberg-Zahl
CCCarlos Cuartas-Vélez
Carlos Cuartas-Vélez
CVColin Veenstra
Colin Veenstra
AMAndries van der Meer
Andries van der Meer
This organ-on-a-chip device of the outer blood retinal barrier will allow future studies of complex disease mechanisms and treatments of visual disorders using clinically relevant endpoints in vitro.

1 June 2019 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
MGMees Graaf
Mees Graaf
ACAmy Cochrane
Amy Cochrane
FHFrancijna E. van Den Hil
Francijna E. van Den Hil
WBWesley Buijsman
Wesley Buijsman
AMAndries van der Meer
Andries van der Meer
VOValeria V. Orlova
Valeria V. Orlova
Blood vessel models are increasingly recognized to have value in understanding disease and drug discovery. However, continued improvements are required to more accurately reflect human vessel physiology. Realistic three-dimensional (3D) in vitro cultures of human vascular cells inside microfluidic chips, or vessels-on-chips (VoC), could contribute to this since they can recapitulate aspects of the in vivo microenvironment by including mechanical stimuli such as shear stress. Here, we used human induced pluripotent stem cells as a source of endothelial cells (hiPSC-ECs), in combination with a technique called viscous finger patterning (VFP) toward this goal. We optimized VFP to create hollow structures in collagen I extracellular-matrix inside microfluidic chips. The lumen formation success rate was over 90% and the resulting cellularized lumens had a consistent diameter over their full length, averaging 336 ± 15 μm. Importantly, hiPSC-ECs cultured in these 3D microphysiological systems formed stable and viable vascular structures within 48 h. Furthermore, this system could support coculture of hiPSC-ECs with primary human brain vascular pericytes, demonstrating their ability to accommodate biologically relevant combinations of multiple vascular cell types. Our protocol for VFP is more robust than previously published methods with respect to success rates and reproducibility of the diameter between- and within channels. This, in combination with the ease of preparation, makes hiPSC-EC based VoC a low-cost platform for future studies in personalized disease modeling.